Literature DB >> 11431741

Navajo neurohepatopathy: a mitochondrial DNA depletion syndrome?

T H Vu1, K Tanji, S A Holve, E Bonilla, R J Sokol, R D Snyder, S Fiore, G H Deutsch, S Dimauro, D De Vivo.   

Abstract

Navajo neurohepatopathy (NNH) is an autosomal recessive disease of full-blooded Navajo children living in the Navajo Reservation of southwestern United States. Clinical features of NNH include peripheral and central nervous system involvement, acral mutilation, corneal scarring or ulceration, liver failure, and metabolic and immunologic derangement. The cause of NNH is unknown, but the clinical features of NNH are similar to those of patients with mitochondrial DNA (mtDNA) depletion. Therefore, we studied mtDNA concentration in the liver from 2 patients with NNH. Using histochemical, biochemical, and molecular techniques, we found evidence of mtDNA depletion, and we propose that the primary defect in NNH is in the nuclear regulation of mtDNA copy number.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431741     DOI: 10.1053/jhep.2001.25921

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  Navajo neurohepatopathy is caused by a mutation in the MPV17 gene.

Authors:  Charalampos L Karadimas; Tuan H Vu; Stephen A Holve; Penelope Chronopoulou; Catarina Quinzii; Stanley D Johnsen; Janice Kurth; Elizabeth Eggers; Lluis Palenzuela; Kurenai Tanji; Eduardo Bonilla; Darryl C De Vivo; Salvatore DiMauro; Michio Hirano
Journal:  Am J Hum Genet       Date:  2006-06-28       Impact factor: 11.025

2.  Encephalomyopathies caused by abnormal nuclear-mitochondrial intergenomic cross-talk.

Authors:  C Lamperti; M Zeviani
Journal:  Acta Myol       Date:  2009-07

Review 3.  Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

Authors:  Luisa Iommarini; Susana Peralta; Alessandra Torraco; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

4.  MPV17 Mutations Causing Adult-Onset Multisystemic Disorder With Multiple Mitochondrial DNA Deletions.

Authors:  Caterina Garone; Juan Carlos Rubio; Sarah E Calvo; Ali Naini; Kurenai Tanji; Salvatore Dimauro; Vamsi K Mootha; Michio Hirano
Journal:  Arch Neurol       Date:  2012-12

5.  Clinical and molecular features of mitochondrial DNA depletion syndromes.

Authors:  A Spinazzola; F Invernizzi; F Carrara; E Lamantea; A Donati; M Dirocco; I Giordano; M Meznaric-Petrusa; E Baruffini; I Ferrero; M Zeviani
Journal:  J Inherit Metab Dis       Date:  2008-12-27       Impact factor: 4.982

Review 6.  Mitochondrial hepatopathies: advances in genetics and pathogenesis.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

Review 7.  Liver disease in mitochondrial disorders.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2007-08       Impact factor: 6.115

Review 8.  Weaving the Strands of Life (Iiná Bitł'ool): History of Genetic Research Involving Navajo People.

Authors:  Rene L Begay; Nanibaa' A Garrison; Franklin Sage; Mark Bauer; Ursula Knoki-Wilson; David H Begay; Beverly Becenti-Pigman; Katrina G Claw
Journal:  Hum Biol       Date:  2020-07-09       Impact factor: 0.553

9.  Post mortem identification of deoxyguanosine kinase (DGUOK) gene mutations combined with impaired glucose homeostasis and iron overload features in four infants with severe progressive liver failure.

Authors:  Ewa Pronicka; Anna Węglewska-Jurkiewicz; Joanna Taybert; Maciej Pronicki; Tamara Szymańska-Dębińska; Agnieszka Karkucińska-Więckowska; Joanna Jakóbkiewicz-Banecka; Paweł Kowalski; Dorota Piekutowska-Abramczuk; Magdalena Pajdowska; Piotr Socha; Jolanta Sykut-Cegielska; Grzegorz Węgrzyn
Journal:  J Appl Genet       Date:  2010-11-16       Impact factor: 3.240

Review 10.  MtDNA-maintenance defects: syndromes and genes.

Authors:  Carlo Viscomi; Massimo Zeviani
Journal:  J Inherit Metab Dis       Date:  2017-03-21       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.